Results 11 to 20 of about 2,365,736 (349)

Dynamics of multi-stage infections on networks [PDF]

open access: yes, 2015
This paper investigates the dynamics of infectious diseases with a nonexponentially distributed infectious period. This is achieved by considering a multistage infection model on networks. Using pairwise approximation with a standard closure, a number of
AJ Black   +59 more
core   +2 more sources

The Spliceosome Factor EFTUD2 Promotes IFN Anti-HBV Effect through mRNA Splicing

open access: yesMediators of Inflammation, 2023
Background/Aims. The underlying mechanisms of differential responsiveness to IFN remain poorly understood. The elongation factor Tu GTP binding domain-containing protein 2 (EFTUD2), involved in RNA splicing and pre-mRNA processing, was recognized as a ...
Pingping Hu   +13 more
doaj   +1 more source

Anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: Potential clinical value [PDF]

open access: yes, 2002
Anti-Saccharomyces cerevisiae antibodies (ASCA) have been described as specific markers in Crohn's disease and their healthy first-degree relatives. 171 patients with Crohn's disease, their 105 first-degree relatives, 145 patients with ulcerative colitis
Folwaczny, Christian   +5 more
core   +1 more source

Disease prevention versus data privacy : using landcover maps to inform spatial epidemic models [PDF]

open access: yes, 2012
The availability of epidemiological data in the early stages of an outbreak of an infectious disease is vital for modelers to make accurate predictions regarding the likely spread of disease and preferred intervention strategies.
A Estrada-Pena   +28 more
core   +6 more sources

Expert consensus on imaging diagnosis of acquired immunodeficiency syndrome associated pneumocystis jirovecii pneumonia [PDF]

open access: yesYixue xinzhi zazhi, 2021
Pneumocystis jirovecii pneumonia (PJP) is a worldwide opportunistic infection disease. Imaging technology had proven to be very useful in early detecting, evaluating and surveillance on chemotherapy.
Radiology Committee on Infectious and Inflammatory Disease   +5 more
doaj   +1 more source

Screening for Latent Tuberculosis Infection using Interferon-Gamma Release Assay Test among Healthcare Workers

open access: yesGlobal Medical & Health Communication, 2023
Healthcare workers (HCWs) represent a significant demographic for screening latent tuberculosis infection (LTBI) due to their potential exposure to infectious patients.
Rosamarlina Rosamarlina   +8 more
doaj   +1 more source

A Real-World Assessment of Clinical Outcomes and Safety of Eravacycline: A Novel Fluorocycline

open access: yesInfectious Diseases and Therapy, 2020
Background Eravacycline is a novel fluorocycline approved for treatment of intraabdominal infections, with a broad spectrum of activity against a range of pathogens including multidrug-resistant species, including ESBL- or KPC-producing isolates.
Nicholas Van Hise   +11 more
doaj   +1 more source

Predictive risk score model for severe fever with thrombocytopenia syndrome mortality based on qSOFA and SIRS scoring system

open access: yesBMC Infectious Diseases, 2020
Background Severe fever with thrombocytopenia syndrome (SFTS) is a severe systemic virus infectious disease usually having multi-organ dysfunction which resembles sepsis.
Li Wang   +3 more
doaj   +1 more source

Novel chemical entities inhibiting Mycobacterium tuberculosis growth identified by phenotypic high-throughput screening

open access: yesScientific Reports, 2022
We performed a high-throughput phenotypic whole cell screen of Mycobacterium tuberculosis against a diverse chemical library of approximately 100,000 compounds from the AbbVie corporate collection and identified 24 chemotypes with anti-tubercular ...
Anuradha Kumar   +17 more
doaj   +1 more source

Tocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS‐CoV‐2

open access: yesClinical and Translational Science, 2021
Tocilizumab is an IL‐6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2).
Russell M. Petrak   +25 more
doaj   +1 more source

Home - About - Disclaimer - Privacy